European equities have outperformed U.S. stocks by the widest margin since 2000 amid optimism about a stabilizing economy, and the prospect of increased fiscal stimulus and an end to war in Ukraine.

President Donald Trump's latest tariff deadline, business leaders, market participants and economists were still guessing ...

Drugmaker AbbVie has agreed to license a weight-loss drug currently in development from Gubra for up to about $2.2 billion, marking its entry into the obesity treatment market.

Anthropic said it raised $3.5 billion in its latest funding round, giving the Amazon- and Google-backed AI startup a $61.5 billion post-money valuation.

Honda Motor plans to produce its next Civic hybrid in Indiana rather than Mexico to avoid the impact of upcoming tariffs, according to a Reuters report.

Palantir shares surged Monday as Wedbush analysts called it one their "top names" to own in 2025, expecting it to benefit from a "tidal wave of spending on AI." ...

The Institute of Supply Management's manufacturing PMI survey for February showed slower-than-expected growth, as tariff ...

Ryan Lasker is a Certified Public Accountant (CPA) who has written about accounting, investing, taxes, and more, for a variety of financial publications.

Broadcom is set to report fiscal first-quarter results after the market closes Thursday, with analysts widely bullish on the chipmaker's stock despite recent losses.

U.S. equities fell at midday on weak economic reports and worries about new tariffs from the Trump administration.

Shares of Sphere Entertainment slid Monday after the company reported declining second-quarter revenue and said its MSG Networks unit may pursue bankruptcy if it can't refinance its debt.

Target is set to report fourth-quarter earnings on Tuesday morning, with analysts largely bullish on the retailer's stock.